Navigating the Challenges of Cyclosporine as an Alternative to Rifampicin as an OATP1B Index Inhibitor.

MLA

Varma, Manthena V. S., and Manoli Vourvahis. “Navigating the Challenges of Cyclosporine as an Alternative to Rifampicin as an OATP1B Index Inhibitor.” Clinical Pharmacology and Therapeutics, Jan. 2025. EBSCOhost, https://doi.org/10.1002/cpt.3564.

APA

Varma, M. V. S., & Vourvahis, M. (2025). Navigating the Challenges of Cyclosporine as an Alternative to Rifampicin as an OATP1B Index Inhibitor. Clinical Pharmacology and Therapeutics. https://doi.org/10.1002/cpt.3564

Chicago

Varma, Manthena V S, and Manoli Vourvahis. 2025. “Navigating the Challenges of Cyclosporine as an Alternative to Rifampicin as an OATP1B Index Inhibitor.” Clinical Pharmacology and Therapeutics, January. doi:10.1002/cpt.3564.